Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples